PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-2.12%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
-8.45%
Cost reduction while CRON.TO shows 4.36% growth. Joel Greenblatt would examine competitive advantage.
21.56%
Positive growth while CRON.TO shows decline. John Neff would investigate competitive advantages.
24.18%
Margin expansion while CRON.TO shows decline. John Neff would investigate competitive advantages.
-68.16%
Both companies reducing R&D. Martin Whitman would check industry innovation trends.
29.49%
G&A growth above 1.5x CRON.TO's 9.23%. Michael Burry would check for operational inefficiency.
-0.68%
Marketing expense reduction while CRON.TO shows 6.11% growth. Joel Greenblatt would examine competitive risk.
-62.02%
Other expenses reduction while CRON.TO shows 21.40% growth. Joel Greenblatt would examine efficiency.
6.28%
Operating expenses growth above 1.5x CRON.TO's 2.33%. Michael Burry would check for inefficiency.
-2.66%
Total costs reduction while CRON.TO shows 3.10% growth. Joel Greenblatt would examine advantage.
-76.74%
Interest expense reduction while CRON.TO shows 90.97% growth. Joel Greenblatt would examine advantage.
27.58%
D&A growth while CRON.TO reduces D&A. John Neff would investigate differences.
630.78%
EBITDA growth while CRON.TO declines. John Neff would investigate advantages.
642.25%
EBITDA margin growth exceeding 1.5x CRON.TO's 15.25%. David Dodd would verify competitive advantages.
123.81%
Operating income growth while CRON.TO declines. John Neff would investigate advantages.
124.33%
Operating margin growth while CRON.TO declines. John Neff would investigate advantages.
23.48%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
40094.44%
Pre-tax income growth while CRON.TO declines. John Neff would investigate advantages.
40963.06%
Pre-tax margin growth while CRON.TO declines. John Neff would investigate advantages.
67.73%
Tax expense growth less than half of CRON.TO's 787.66%. David Dodd would verify if advantage is sustainable.
645.04%
Net income growth while CRON.TO declines. John Neff would investigate advantages.
661.14%
Net margin growth while CRON.TO declines. John Neff would investigate advantages.
22200.00%
EPS growth while CRON.TO declines. John Neff would investigate advantages.
22200.00%
Diluted EPS growth while CRON.TO declines. John Neff would investigate advantages.
5.52%
Share count increase while CRON.TO reduces shares. John Neff would investigate differences.
6.15%
Diluted share reduction below 50% of CRON.TO's 0.55%. Michael Burry would check for concerns.